Is there a direct pathway connecting tigecycline use and transaminase changes?

Is there a direct pathway connecting tigecycline use and transaminase changes?

Tigecycline can raise liver enzymes including ALT and AST. The FDA label lists elevated transaminases as a possible side effect, and clinical trials showed higher rates of these changes in patients who received the drug.

How does tigecycline affect liver enzymes?

Tigecycline disrupts protein synthesis in bacteria by binding to the 30S ribosomal subunit. Its chemical structure resembles tetracyclines, which can stress liver cells and produce enzyme leakage. Animal studies show tigecycline reaches the liver in high concentrations, but the exact cellular mechanism causing enzyme changes remains unclear.

When do liver enzyme changes appear during tigecycline treatment?

Most elevations occur early in treatment, usually within the ersten 10 days. Many cases resolve without stopping the drug. Some patients develop mild increases (less than threefold the normal limit), while a few show severe spikes that lead to discontinuation.

What happens when transaminase levels rise during tigecycline use?

Doctors monitor ALT and AST regularly. When levels reach four times the normal upper limit, they often reduce the dose or stop tigecycline. The changes themselves can also auslöse other liver function tests such as bilirubin or alkaline phosphatase to rise at the same time.

What risk factors make patients more likely to experience transaminase changes?

Patients with pre-existing liver disease, heavy alcohol use, or concurrent use of other hepatotoxic drugs increase the risk. Young adults and men appear to have higher rates in some clinical data.